Crispr And Intellia: Advancing In Vivo Gene Editing As 2025 Results Strengthen Investment Outlook

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...
Forbes

This Scientist Is Building Custom Gene-Editing Tools—And Stands To Make Billions

In 2013, Benjamin Oakes was hellbent on getting his PhD while working on the bleeding edge of molecular engineering: refining a gene editing tool, Crispr, that promised to some day cut DNA as ...
STAT

Intellia pauses two late-stage CRISPR gene-editing trials after emergence of safety concern

Intellia Therapeutics said it is pausing two late-stage CRISPR gene-editing trials after a patient in one study was hospitalized with liver damage.
Scientific American

Next-Gen CRISPR and the Future of Gene Editing

The practice of genetic modification is as old as humanity. For thousands of years, humans have bred crops, livestock and even pets that possess desirable traits. This selective process, which alters ...
Yahoo Finance

A Look at CRISPR Therapeutics’s (CRSP) Valuation Following First Public SyNTase Gene Editing Data Reveal

CRISPR Therapeutics (CRSP) just announced that its SyNTase gene editing technology will be featured in an oral presentation at the ESGCT 2025 Congress. This marks the first major public unveiling of ...
New York Post

Could Down syndrome be eliminated? Scientists say cutting-edge gene editing tool could cut out extra chromosome

Cutting-edge gene editing technology could eradicate Down syndrome, according to Japanese scientists. Down syndrome, which causes a range of developmental differences and affects 1 in 700 newborns in ...

The Best CRISPR Companies to Invest In

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping the future of medicine and genetics.
NPR

Customized CRISPR treatments could help people with rare genetic disorders

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders. A gene-editing ...
Scientific American

FDA Approves First CRISPR Gene Editing Treatment for Sickle Cell Disease

CRISPR, the gene-editing technology that has revolutionized biological research, is finally available as a medical treatment with regulatory approval. On December 8 the U.S. Food and Drug ...
Purdue University

Blueprints for a molecular machine more powerful than CRISPR

WEST LAFAYETTE, Ind. — More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, revolutionizing the ability to edit genes and ...
Fast Company

The FDA just approved the first CRISPR gene-editing drug in the U.S. Here’s what you need to know

On Friday, the U.S. Food and Drug Administration (FDA) approved a pair of gene therapies for the painful and potentially fatal blood disorder, sickle cell disease (SCD)–including the first-ever CRISPR ...